| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_53b0201dd880279850d3501b1f1cb340
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_745f083d5d32bed4c33e300c71f44fba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_45d8cab40fb6018ff5e4bbcb031514b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24d41624f4c12622605b7048517fe8f7 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 |
| filingDate |
2010-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb16ef42fac277506ef31b4fb5b65dcd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ddbbac24b0e5015c10b05a40b3749e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89c7beff9e0596d30fd234c3c3a3c0f2 |
| publicationDate |
2010-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010101989-A1 |
| titleOfInvention |
PHARMACEUTICAL COMPOSITION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE |
| abstract |
The present invention relates to development of efficacious pharmaceutical implant compositions comprising an active agent in a therapeutically effective amount and a polyethylene glycol having a molecular weight of at least 2000. |
| priorityDate |
2009-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |